Evaluation of Primary Brain Tumors With FLT-PET: Usefulness and Limitations
Authors:
- 1 December 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 31 (12) , 774-780
Abstract
Purpose of the Report: The purpose of this report was to investigate the potential of positron emission tomography using F-18 fluorodeoxythymidine (FLT-PET) in evaluating primary brain tumors. Materials and Methods: FLT-PET was performed in 25 patients with primary brain tumors. FLT uptake in the lesion was semiquantitatively evaluated by measuring the maximal standardized uptake value (SUVmax) and the tumor-to-normal tissue ratio (TNR). SUVmax and TNR were compared with the histologic grade and the expression of the proliferation marker (Ki-67). Results: FLT uptake in normal brain parenchyma was very low, resulting in the visualization of brain tumors with high contrast. Both SUVmax and TNR significantly correlated with the malignant grade of brain gliomas, in which high SUVmax/TNR was obtained for high-grade gliomas. Patients with primary lymphoma also showed SUVmax/TNR equivalent to glioblastoma. There was a positive correlation between SUVmax/TNR and the Ki-67 index. In contrast, spuriously high SUVmax and TNR were obtained in 3 of 6 patients with suspected recurrent tumors (2 patients with recurrent grade 2 glioma and one patient with postoperative granuloma), all of which showed lesion enhancement on MRI after Gd administration. Conclusions: FLT-PET can be used to evaluate the malignant grade and proliferation activity of primary brain tumors, especially malignant brain tumors. However, the presence of benign lesions showing blood–brain barrier disruption cannot be distinguished from malignant tumors and needs to be carefully evaluated.Keywords
This publication has 14 references indexed in Scilit:
- FDG PET of Infection and InflammationRadioGraphics, 2005
- [18F]FLT-PET in oncology: current status and opportunitiesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Metabolic Imaging with FDGThe Cancer Journal, 2004
- The combination of mitotic and Ki-67 indices as a useful method for predicting short-term recurrence of meningiomasSurgical Neurology, 2004
- Imaging gliomas with positron emission tomography and single-photon emission computed tomographySeminars in Nuclear Medicine, 2003
- Positron emission tomography imaging of brain tumorsNeuroimaging Clinics Of North America, 2002
- Performance assessment of O-18 water purifierAnnals of Nuclear Medicine, 2001
- Imaging proliferation in vivo with [F-18]FLT and positron emission tomographyNature Medicine, 1998
- The use of PET in evaluating patients with primary brain tumours: is it useful?Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Human thymidine kinase 1. Regulation in normal and malignant cellsAdvances in Enzyme Regulation, 1995